I now have comprehensive information. Here is the full diagnosis and management:
Diagnosis: Pseudomonas Toe Web Infection (Gram-Negative Toe Web Infection)
The image shows the interdigital/plantar web space with:
- Blue-green discoloration - the hallmark of pyocyanin pigment produced by Pseudomonas aeruginosa
- Thickened, macerated skin with a "moth-eaten" appearance
- Yellow-green purulent exudate in the web space
- Extension toward the sole of the foot
This is classic gram-negative toe web infection (GNTWI), with Pseudomonas aeruginosa as the most common causative organism. The blue-green pigment (pyocyanin) is essentially pathognomonic.
Background
P. aeruginosa is a ubiquitous Gram-negative rod recognized by its characteristic sweet, grape-like odor and the blue-green color conferred by pyocyanin. It thrives in moist environments and requires a breach in skin integrity to establish cutaneous infection - typically via maceration, prior fungal infection (tinea pedis), or prolonged occlusion.
Predisposing factors:
- Persistently wet feet in heat and humidity
- Occlusive footwear
- Pre-existing tinea pedis or dermatophyte infection (very common co-infection)
- Diabetes, immunosuppression
Differential Diagnosis
| Condition | Distinguishing feature |
|---|
| Tinea pedis (interdigital) | White maceration, no green discoloration; KOH+ |
| Erythrasma (Corynebacterium) | Coral-red fluorescence on Wood lamp |
| Pitted keratolysis | Plantar pits, malodor, no green pigment |
| Mixed bacterial/fungal intertrigo | Culture required |
Diagnosis
- Clinical diagnosis is possible when blue-green pigment is visible
- Bacterial culture from wound swab/debridement confirms P. aeruginosa and guides antibiotic sensitivity
- Fungal culture / KOH prep - always check for co-existing dermatophyte infection, which is extremely common
- Wood lamp: white/green fluorescence in green nail syndrome variant
Management
Both antifungal and antibacterial therapy are typically required, as tinea pedis frequently co-exists and may have been the initial predisposing factor.
1. Local / Topical Measures (first-line for localized disease)
- Acetic acid soaks (2-5% white vinegar soaks, 15-20 min twice daily) - effective against Pseudomonas, cheap, and well-tolerated
- Topical gentamicin (cream/solution) applied to affected web space
- Castellani paint (magenta paint) or gentian violet - antiseptic solutions with proven efficacy
- Wound debridement - remove necrotic/macerated tissue
- Antifungal (topical clotrimazole, miconazole, or terbinafine) for co-existing tinea pedis
2. Systemic Antibiotics (for extensive disease, cellulitis, or immunocompromised patients)
- Ciprofloxacin 500 mg PO twice daily x 7-14 days is the oral agent of choice (excellent Pseudomonal activity)
- Duration guided by clinical response
- IV antipseudomonal agents (piperacillin-tazobactam, ceftazidime) reserved for severe/spreading infection
3. Preventive / Supportive Measures
- Keep feet dry; change socks regularly; use open footwear when possible
- Dry thoroughly between toes after washing
- Treat underlying tinea pedis aggressively to prevent recurrence
- In diabetic patients: thorough evaluation for ulceration, deep tissue involvement, and osteomyelitis
4. Red Flags Requiring Urgent Assessment
- Signs of cellulitis (spreading erythema, warmth, lymphangitis)
- Fever / systemic symptoms - may indicate bacteremia
- Diabetic foot - risk of deep tissue infection and osteomyelitis
- Ecthyma gangrenosum - hemorrhagic, necrotic ulcers suggesting bacteremia in immunocompromised patients
Key Teaching Points
- The blue-green color = pyocyanin pigment = P. aeruginosa until proven otherwise
- Always treat the fungal component - tinea pedis is the most common predisposing condition
- Acetic acid soaks + topical gentamicin are sufficient for mild-moderate localized disease
- Ciprofloxacin PO for moderate-severe or non-responsive cases
- Consider underlying diabetes and check glycemic control
Sources: Fitzpatrick's Dermatology, Vol. 1-2, Chapter 154; Waterton & Lipner, "Gram-Negative Toe Web Infections," Dermatol Pract Concept 2024 [PMID: 38364399]; Goldman-Cecil Medicine